Michelle,
bacteriostatic and fugistatic properties are typically determined by the materials used in your device . So you typically perform B&F testing during (initial) validation and again when you change something in your product that might have an impact on the initial B&F test results.
Note that within the framework of ISO 11137-1 you release product from routine gamma sterilization by verifying whether the delivered routine dose for the batch is in the specified range; You do not perform tests of sterility when you release routine product.
Hope this helps,